Case Control Study
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Orthop. Jun 18, 2021; 12(6): 386-394
Published online Jun 18, 2021. doi: 10.5312/wjo.v12.i6.386
Evidence-based approach to providing informed consent for hip fracture surgery during the COVID-19 era
Rory Cuthbert, David Ferguson, Babar Kayani, Saeef Haque, Aoun Ali, Asif Parkar, Peter Bates, Krishna Vemulapalli
Rory Cuthbert, David Ferguson, Saeef Haque, Aoun Ali, Asif Parkar, Krishna Vemulapalli, Department of Trauma & Orthopaedic Surgery, Queen's Hospital-Romford, London RM7 0AG, United Kingdom
Babar Kayani, Peter Bates, Department of Trauma & Orthopaedic Surgery, Royal London Hospital, London E1 1FR, United Kingdom
Author contributions: Cuthbert R designed the research study, performed data acquisition, and wrote the manuscript; Ferguson D and Kayani B designed the research study and performed data acquisition; Haque S and Ali A performed data acquisition; Parkar A, Bates P and Vemulapalli K contributed towards conception of the study and final editing; all authors revised the article critically for important intellectual content, and provided final approval for the paper to be published.
Institutional review board statement: Local research approval was obtained from respective departmental leads, and the NHS Research Ethics Committee decision tool excluded need for ethical review.
Informed consent statement: Informed consent was not required for the above study as data was collected retrospectively and anonymized.
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
Data sharing statement: No additional data are available.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Rory Cuthbert, BSc, MBBS, Surgeon, Department of Trauma & Orthopaedic Surgery, Queen's Hospital-Romford, Rom Valley Way, London RM7 0AG, United Kingdom. rory.cuthbert@nhs.net
Received: February 22, 2021
Peer-review started: February 22, 2021
First decision: May 3, 2021
Revised: May 15, 2021
Accepted: May 25, 2021
Article in press: May 25, 2021
Published online: June 18, 2021
Processing time: 109 Days and 13.3 Hours
Core Tip

Core Tip: Coronavirus disease 2019 positive patients undergoing hip fracture surgery should be consented for the increased risk of postoperative complications (including lower respiratory tract infection, acute respiratory distress syndrome, deep vein thrombosis and pulmonary embolism), increased requirement for intensive care admission, longer inpatient stay and a higher risk of mortality. It is medicolegally imperative that these risks are addressed as part of an informed consent process.